Amgen Inc. buy phonebroker
Start price
03.11.16
/
50%
€123.55
Target price
03.03.17
€162.36
Performance (%)
33.25%
End price
03.03.17
€162.70
Summary
This prediction ended on 03.03.17 with a price of €162.70. With a performance of 33.25% the BUY prediction by phonebroker was a big success. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 3.747% | 3.747% | 26.709% | 53.621% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 03.11.2016 dem Buy-Gesamtsentiment mit dem Kursziel 180 USD zu.